{"name": "Cadence Pharmaceuticals",
 "permalink": "cadence-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/cadence-pharmaceuticals",
 "homepage_url": "http://www.cadencepharm.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2004,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": null,
 "alias_list": "",
 "email_address": "info@cadencepharm.com",
 "phone_number": "858-436-1400",
 "description": "Biopharmaceutical company",
 "created_at": "Tue Dec 15 21:35:04 UTC 2009",
 "updated_at": "Wed Mar 13 11:55:23 UTC 2013",
 "overview": "\u003Cp\u003ECadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. On May 4, 2010 Cadence resubmitted a New Drug Application for its investigational product candidate, OFIRMEVTM (acetaminophen) injection for the treatment of pain and fever in adults and children. The FDA has assigned a new Prescription Drug User Fee Act (PDUFA) action date for OFIRMEV of November 4, 2010.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       43],
      "assets/images/resized/0009/1445/91445v1-max-150x150.png"],
     [[250,
       72],
      "assets/images/resized/0009/1445/91445v1-max-250x250.png"],
     [[403,
       117],
      "assets/images/resized/0009/1445/91445v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President \u0026 CEO",
    "person":
     {"first_name": "Theodore",
      "last_name": "R. Schroeder",
      "permalink": "theodore-r-schroeder",
      "image":
       {"available_sizes":
         [[[112,
            150],
           "assets/images/resized/0024/2201/242201v1-max-150x150.jpg"],
          [[188,
            250],
           "assets/images/resized/0024/2201/242201v1-max-250x250.jpg"],
          [[338,
            450],
           "assets/images/resized/0024/2201/242201v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Senior Vice President, Chief Financial Officer, Treasurer and Assistant Secretary",
    "person":
     {"first_name": "William",
      "last_name": "R. LaRue",
      "permalink": "william-r-larue",
      "image":
       {"available_sizes":
         [[[112,
            150],
           "assets/images/resized/0024/2202/242202v1-max-150x150.jpg"],
          [[188,
            250],
           "assets/images/resized/0024/2202/242202v1-max-250x250.jpg"],
          [[338,
            450],
           "assets/images/resized/0024/2202/242202v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Director",
    "person":
     {"first_name": "James",
      "last_name": "Blair",
      "permalink": "james-blair",
      "image": null}},
   {"is_past": false,
    "title": "Board Member",
    "person":
     {"first_name": "Brian",
      "last_name": "Atwood",
      "permalink": "brian-atwood",
      "image":
       {"available_sizes":
         [[[112,
            150],
           "assets/images/resized/0026/4120/264120v1-max-150x150.jpg"],
          [[187,
            250],
           "assets/images/resized/0026/4120/264120v1-max-250x250.jpg"],
          [[225,
            300],
           "assets/images/resized/0026/4120/264120v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [{"price_amount": 285000000.0,
    "price_currency_code": "USD",
    "term_code": null,
    "source_url": "http://www.tradingmarkets.com/news/stock-alert/cadx_cadence-pharmaceuticals-to-acquire-incline-therapeutics-998859.html",
    "source_description": "Cadence Pharmaceuticals to acquire Incline Therapeutics",
    "acquired_year": 2010,
    "acquired_month": 6,
    "acquired_day": 22,
    "company":
     {"name": "Incline Therapeutics",
      "permalink": "incline-therapeutics",
      "image":
       {"available_sizes":
         [[[150,
            54],
           "assets/images/resized/0024/6779/246779v1-max-150x150.jpg"],
          [[185,
            67],
           "assets/images/resized/0024/6779/246779v1-max-250x250.jpg"],
          [[185,
            67],
           "assets/images/resized/0024/6779/246779v1-max-450x450.jpg"]],
        "attribution": null}}}],
 "offices":
  [{"description": "",
    "address1": "12481 High Bluff Drive",
    "address2": "Suite 200",
    "zip_code": "92130",
    "city": "San Diego",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        106],
       "assets/images/resized/0024/2203/242203v1-max-150x150.jpg"],
      [[250,
        177],
       "assets/images/resized/0024/2203/242203v1-max-250x250.jpg"],
      [[450,
        318],
       "assets/images/resized/0024/2203/242203v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}